Workflow
Medical Devices
icon
搜索文档
Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis
Globenewswire· 2025-11-14 05:05
SOUTH JORDAN, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that the U.S. Centers for Medicare & Medicaid Services (“CMS”) has notified Merit that its application for Transitional Pass-Through (“TPT”) incremental payment for WRAPSODY® Cell-Impermeable Endoprosthesis (“CIE”) procedures in the outpatient and ambulatory surgery center (“ASC”) settings requires further consideration prior to CMS making a final decisi ...
RenovoRx Reports Third Quarter 2025 Financial Results, Including Approximately $900,000 in Year-to-Date Revenue, and Provides Business Update
Globenewswire· 2025-11-14 05:05
September 30, 2025 Cash and Cash Equivalents at $10 million Revenue Expected to Grow in 2026 and Continue to Offset Cash Burn Management to Host Conference Call Today at 4:30 p.m. ET MOUNTAIN VIEW, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (Nasdaq: RNXT) (“RenovoRx” or the “Company”), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared drug-delivery device, today announced its financial results and provided a busines ...
CapsoVision Reports Third Quarter 2025 Financial Results
Globenewswire· 2025-11-14 05:05
SARATOGA, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today reported financial results for its third quarter ended September 30, 2025. Recent Highlights Third quarter 2025 revenue was $3.5 million, a 19% increase over the third quarter of 2024.New accounts grew 31% in the third quarter of 2025 over the comparable quarter in 2024.CapsoCam Plus® used by over 151,0 ...
Class Action Alert: Levi & Korsinsky Reminds DexCom, Inc. (DXCM) Investors of December 26, 2025 Deadline
Newsfile· 2025-11-14 04:44
New York, New York--(Newsfile Corp. - November 13, 2025) - If you suffered a loss on your DexCom, Inc. (NASDAQ: DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/dexcom-inc-lawsuit-submission-form-2?prid=177268&wire=5&utm_campaign=17or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.THE LAWSUIT: A ...
STXS Secures FDA Approval for GenesisX to Broaden Surgical Robotics
ZACKS· 2025-11-14 04:01
Key Takeaways STXS gains FDA 510(k) clearance for GenesisX, its next-generation endovascular robotics system.GenesisX removes installation hurdles with compact design, standard power use, and no structural changes.STXS begins a limited U.S. and Europe launch while expanding catheter options and imaging integration.Stereotaxis (STXS) recently secured FDA 510(k) clearance for GenesisX, its next-generation robotic system designed to make endovascular surgical robotics far more accessible. The approval marks a ...
BDX Unveils Portable PureWick System for On-the-Go Incontinence Care
ZACKS· 2025-11-14 04:01
Key Takeaways BD launches a portable PureWick system to support discreet, mobile incontinence management.The device adapts hospital-trusted PureWick tech to a lighter, battery-powered, user-friendly format.The expansion targets rising home-care demand and strengthens BD's urology and critical care presence.Becton, Dickinson and Company (BDX) , popularly known as BD, expanded its PureWick portfolio with a new first-of-its-kind Portable Collection System designed to help wheelchair users manage urinary incont ...
Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Businesswire· 2025-11-14 03:39
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Zimmer Biomet Holdings, Inc. ("Zimmer†or the "Company†) (NYSE: ZBH) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ZIMMER BIOMET HOLDINGS, INC. (ZBH), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happ. ...
Stryker (NYSE:SYK) 2025 Earnings Call Presentation
2025-11-14 03:30
Opening video 2025 Investor Day 2 Built for growth November 13, 2025 2025 Investor Day 1 2025 Investor Day Jason Beach Vice President, Finance and Investor Relations 2025 Investor Day 3 Agenda | Built for growth | Kevin Lobo, Chair and Chief Executive Officer | | --- | --- | | Customer -focused innovation | Spencer Stiles, Group President, Orthopaedics | | Spotlight: Power brands | Dylan Crotty, President, Instruments | | Spotlight: Mako 4 and Triathlon Gold | Kathy Truppi, President, Joint Replacement | | ...
All You Need to Know About Tactile Systems Technology (TCMD) Rating Upgrade to Strong Buy
ZACKS· 2025-11-14 02:01
Tactile Systems Technology (TCMD) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the sy ...
Kelyniam Global Secures Exclusive U.S. License for Evonik's VESTAKEEP® Fusion Biomaterial in Cranial Implants
Globenewswire· 2025-11-14 01:47
CANTON, Conn., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Kelyniam Global, Inc. (OTC: KLYG), a leader in custom cranial and craniofacial implants, today announced it has secured an exclusive U.S. license from Evonik Industries AG to market VESTAKEEP® Fusion, a bi-calcium phosphate-infused PEEK material, for cranial, craniofacial, and maxillofacial implants. This agreement grants Kelyniam two years of exclusivity with the option for renewal upon mutual agreement. The license enhances Kelyniam's regenerative product l ...